Trial intelligence / Profile preview

CNS Effects of Hormone Replacement in Induced Hypogonadism

NCT00001322Phase 2Completed

Sponsor
National Institute of Mental Health
Start
Jun 1994
Primary completion
Mar 2020
Modality
Peptides, Small Molecules
Countries
1
01

Overview

A Phase 2 trial of leuprolide, estradiol topical, Crinone in Premenstrual Dysphoric Disorder (PMDD), sponsored by National Institute of Mental Health. Started Jun 1994; status: completed.

02

Drugs

leuprolideestradiol topicalCrinone
03

Conditions

Premenstrual Dysphoric Disorder (PMDD)

Beyond the preview

Go deeper on NCT00001322.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00001322.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call